Home/Filings/4/0001193125-25-307215
4//SEC Filing

Kline Kyle 4

Accession 0001193125-25-307215

CIK 0001237831other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 8:23 PM ET

Size

19.5 KB

Accession

0001193125-25-307215

Insider Transaction Report

Form 4
Period: 2025-12-01
Kline Kyle
Senior Vice President, CFO
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-12-01$53.14/sh+3,646$193,7483,646 total
  • Exercise/Conversion

    Class A Common Stock

    2025-12-01$56.43/sh+5,000$282,1508,646 total
  • Exercise/Conversion

    Class A Common Stock

    2025-12-01$63.68/sh+4,896$311,77718,542 total
  • Sale

    Class A Common Stock

    2025-12-01$90.00/sh18,542$1,668,7800 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2025-12-013,6461,354 total
    Exercise: $53.14Exp: 2033-03-24Class A Common Stock (3,646 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2025-12-015,00010,000 total
    Exercise: $56.43Exp: 2034-02-27Class A Common Stock (5,000 underlying)
Footnotes (5)
  • [F1]This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.
  • [F2]These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F3]These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F4]These options were granted on January 25, 2021 and are fully vested.
  • [F5]These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Documents

1 file

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0002080625

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:23 PM ET
Size
19.5 KB